StrideBio: Ginkgo Bioworks buys North Carolina startup's gene therapy platform
The future of a North Carolina-based gene therapy company founded by a Duke University professor is unclear now that it has sold its main platform.
Read full article »
StrideBio is a North Carolina-based biotechnology firm that develops and commercializes gene therapies for the treatment of CNS and cardiovascular disorders.
Read more